Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Return on Equity (2022 - 2025)

Praxis Precision Medicines has reported Return on Equity over the past 4 years, most recently at 0.53% for Q4 2025.

  • Quarterly results put Return on Equity at 0.53% for Q4 2025, down 5.0% from a year ago — trailing twelve months through Dec 2025 was 0.53% (down 5.0% YoY), and the annual figure for FY2025 was 0.49%, up 28.0%.
  • Return on Equity for Q4 2025 was 0.53% at Praxis Precision Medicines, up from 0.78% in the prior quarter.
  • Over the last five years, Return on Equity for PRAX hit a ceiling of 0.41% in Q2 2024 and a floor of 2.62% in Q1 2023.
  • Median Return on Equity over the past 4 years was 0.78% (2025), compared with a mean of 1.12%.
  • Biggest five-year swings in Return on Equity: surged 175bps in 2024 and later crashed -37bps in 2025.
  • Praxis Precision Medicines' Return on Equity stood at 2.37% in 2022, then skyrocketed by 32bps to 1.62% in 2023, then surged by 70bps to 0.48% in 2024, then decreased by -10bps to 0.53% in 2025.
  • The last three reported values for Return on Equity were 0.53% (Q4 2025), 0.78% (Q3 2025), and 0.64% (Q2 2025) per Business Quant data.